Position in NVO
as of Jun 30, 2026
· filed Aug 4, 2026
Position Value
$6,446,012
+$2,206,233 QoQ
Shares Held
134,460
+61.4% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.11%
of 13F equity value
Holder Rank
#184
of 1,348 holders
Holding Since
Mar 2025
5 quarters on record
Voting authority
Sole 1%
Shared 0%
None 99%
Common Shares in NVO Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026TODD ASSET MANAGEMENT LLC holds $250,852,520 across 11 Drug Manufacturers - General names. NVO ranks #6 (2.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
282,442 | $71,073,704 | |
| 2 | GILD |
Gilead Sciences, Inc.
|
421,984 | $53,313,458 | |
| 3 | NVS |
Novartis AG
|
317,429 | $49,747,472 | |
| 4 | AMGN |
Amgen Inc
|
108,134 | $39,157,483 | |
| 5 | SNY |
Sanofi
|
674,143 | $28,758,939 | |
| 6 | NVO |
Novo Nordisk A S
This page
|
134,460 | $6,446,012 | |
| 7 | JNJ |
Johnson & Johnson
|
3,288 | $835,053 | |
| 8 | PFE |
Pfizer Inc
|
27,801 | $669,448 |
All Filings in NVO
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $6,446,012 | 134,460 | Shares | Sole | 2026-08-04 | |
| 2025-12-31 | $4,239,779 | 83,329 | Shares | Sole | 2026-02-09 | |
| 2025-09-30 | $3,405,532 | 61,372 | Shares | Sole | 2025-11-07 | |
| 2025-06-30 | $3,985,214 | 57,740 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $2,853,984 | 41,100 | Shares | Sole | 2025-05-12 | |
| No filing history on record for this holder in this stock. | ||||||